Messenger RNA vaccines: Now proven against coronavirus, the technology can do so much more | CNN
JCI - Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models
Genital Herpes News, Research
Researcher with Type 1 Diabetes Is Behind the COVID-19 Vaccines
Genital Herpes Vaccine Is a Winner in Animals. Next Up: Testing on Humans - Be part of the knowledge - ReachMD
World Immunization Week 2018 - Penn Medicine
Herpes vaccine is a winner in animals. Next up: Testing on humans.
:max_bytes(150000):strip_icc()/FDA-Planning-to-Warn-of-Guillain-Barre-Syndrome-Linked-to-Johnson-Johnson-Vaccine-GettyImages-515388300-1164571016--2000-874ab2ab9da9409688e03478896e6287.jpg "J&J COVID Vaccine Linked to Guillain-Barré Syndrome")
J&J COVID Vaccine Linked to Guillain-Barré Syndrome
From foundational discoveries to profound impact | Penn Today
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection | PLOS Pathogens
Harvey M. Friedman | Faculty | About Us | Perelman School of Medicine | Perelman School of Medicine at the University of Pennsylvania
Vital Signs: Winter 2021 Magazine | Penn Medicine
New HSV-2 Vaccine Uses mRNA to Treat Herpes in Mice | Penn Medicine
New Genital Herpes Vaccine Candidate Provides Powerful Protection in Preclinical Tests - Penn Medicine
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection | PLOS Pathogens
Home | The Weissman Lab | Perelman School of Medicine at the University of Pennsylvania
Penn's genital herpes vaccine is a winner in animals. Next up: Testing on humans.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/XA3ISOF3EROIZE3YJWGU3K4IF4.jpg "BioNTech doses first patient in herpes vaccine candidate clinical trial | Reuters")
BioNTech doses first patient in herpes vaccine candidate clinical trial | Reuters
mRNA Vaccines for Infectious Diseases Beyond COVID-19 | Penn Medicine
Extremely promising new herpes vaccine moves closer to human trials
Messenger RNA vaccines: Now proven against coronavirus, the technology can do so much more | CNN
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes | Science Immunology
Penn Medicine researchers develop vaccine for genital herpes | The Daily Pennsylvanian
A new herpes vaccine leaves no trace of infection or disease | Penn Today
Laying the Groundwork for COVID-19 Vaccines: Dr. Drew Weissman and mRNA Technology at Penn Medicine - YouTube
Shingles Vaccine and IBD Research at Penn - Penn Medicine
New vaccine prevents genital herpes in mice and guinea pigs
Uptake of herpes zoster vaccine linked to supply | ACP Internist
COVID vaccine's mRNA technology also works for HIV vaccine - WHYY
